SYN-004 (ribaxamase) Protects the Diversity of the Gut Microbiome in Patients Receiving Intravenous Ceftriaxone TreatmentJohn F. Kokai-Kun,Sheila Connelly,Charles Le,Kenneth Trout,Joseph SlimanOpen Forum Infectious Diseases(2017)引用 2|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要